Global Fluorine-18 Radiopharmaceuticals Market Growth 2026-2032
The global Fluorine-18 Radiopharmaceuticals market size is predicted to grow from US$ 196 million in 2025 to US$ 313 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.
Fluorine-18 radiopharmaceuticals are specialized diagnostic agents utilized primarily in Positron Emission Tomography (PET) imaging. These compounds are synthesized by labeling biologically active molecules—such as glucose analogs, amino acids, or receptor-specific ligands—with the radioisotope Fluorine-18 . Due to its physical properties, including a positron-emitting decay mode and an optimal half-life of approximately 109.8 minutes, F18 is considered the gold standard for clinical molecular imaging. These radiopharmaceuticals enable the non-invasive visualization and quantification of metabolic, physiological, and pathological processes at the cellular level, playing a critical role in the precise diagnosis, staging, and monitoring of oncological, neurological, and cardiovascular diseases.
This Insight Report provides a comprehensive analysis of the global Fluorine-18 Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluorine-18 Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorine-18 Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorine-18 Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorine-18 Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluorine-18 Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Fluorine-18 radiopharmaceuticals are specialized diagnostic agents utilized primarily in Positron Emission Tomography (PET) imaging. These compounds are synthesized by labeling biologically active molecules—such as glucose analogs, amino acids, or receptor-specific ligands—with the radioisotope Fluorine-18 . Due to its physical properties, including a positron-emitting decay mode and an optimal half-life of approximately 109.8 minutes, F18 is considered the gold standard for clinical molecular imaging. These radiopharmaceuticals enable the non-invasive visualization and quantification of metabolic, physiological, and pathological processes at the cellular level, playing a critical role in the precise diagnosis, staging, and monitoring of oncological, neurological, and cardiovascular diseases.
- In 2025, global Fluorine-18 radiopharmaceuticals production reached approximately 2 million GBq, and average price was 100 USD/GBq?with gross margin 65%
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Fluorine-18 Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Fluorine-18 Radiopharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Fluorine-18 Radiopharmaceuticals sales for 2026 through 2032. With Fluorine-18 Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorine-18 Radiopharmaceuticals industry.This Insight Report provides a comprehensive analysis of the global Fluorine-18 Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluorine-18 Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorine-18 Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorine-18 Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorine-18 Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluorine-18 Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Nucleophilic Labeling
- Electrophilic Labeling
Segmentation by Functional:
- Metabolic Tracers
- Receptor-Binding Tracers
- Amino Acid Transporters
- Others
Segmentation by Specific Activity:
- High Specific Activity
- Low Specific Activity
Segmentation by Application:
- Medical Imaging
- Scientific Research
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ANSTO
- Rosatom
- Eckert & Ziegler
- CNNC
- Curium Pharma
- GE HealthCare
- Jubilant Radiopharma
- Cardinal Health
- IBA
- Sumitomo Heavy Industries
- Sinotau
- Nueclear Healthcare
- DC Pharma
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Fluorine-18 Radiopharmaceuticals market?
- What factors are driving Fluorine-18 Radiopharmaceuticals market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Fluorine-18 Radiopharmaceuticals market opportunities vary by end market size?
- How does Fluorine-18 Radiopharmaceuticals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fluorine-18 Radiopharmaceuticals by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fluorine-18 Radiopharmaceuticals by Country/Region, 2021, 2025 & 2032
2.2 Fluorine-18 Radiopharmaceuticals Segment by Type
2.2.1 Nucleophilic Labeling
2.2.2 Electrophilic Labeling
2.2.3 Fluorine-18 Radiopharmaceuticals Sales by Type
2.2.3.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Type (2021-2026)
2.3 Fluorine-18 Radiopharmaceuticals Segment by Functional
2.3.1 Metabolic Tracers
2.3.2 Receptor-Binding Tracers
2.3.3 Amino Acid Transporters
2.3.4 Others
2.3.5 Fluorine-18 Radiopharmaceuticals Sales by Functional
2.3.5.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional (2021-2026)
2.3.5.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Functional (2021-2026)
2.3.5.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Functional (2021-2026)
2.4 Fluorine-18 Radiopharmaceuticals Segment by Specific Activity
2.4.1 High Specific Activity
2.4.2 Low Specific Activity
2.4.3 Fluorine-18 Radiopharmaceuticals Sales by Specific Activity
2.4.3.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity (2021-2026)
2.4.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Specific Activity (2021-2026)
2.4.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Specific Activity (2021-2026)
2.5 Fluorine-18 Radiopharmaceuticals Segment by Application
2.5.1 Medical Imaging
2.5.2 Scientific Research
2.5.3 Fluorine-18 Radiopharmaceuticals Sales by Application
2.5.3.1 Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2021-2026)
2.5.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fluorine-18 Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Company (2021-2026)
3.1.2 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company (2021-2026)
3.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Company (2021-2026)
3.2.1 Global Fluorine-18 Radiopharmaceuticals Revenue by Company (2021-2026)
3.2.2 Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company (2021-2026)
3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Fluorine-18 Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fluorine-18 Radiopharmaceuticals Product Location Distribution
3.4.2 Players Fluorine-18 Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLUORINE-18 RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Fluorine-18 Radiopharmaceuticals Market Size by Geographic Region (2021-2026)
4.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fluorine-18 Radiopharmaceuticals Market Size by Country/Region (2021-2026)
4.2.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fluorine-18 Radiopharmaceuticals Sales Growth
4.4 APAC Fluorine-18 Radiopharmaceuticals Sales Growth
4.5 Europe Fluorine-18 Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Fluorine-18 Radiopharmaceuticals Sales by Country
5.1.1 Americas Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
5.1.2 Americas Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
5.2 Americas Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
5.3 Americas Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fluorine-18 Radiopharmaceuticals Sales by Region
6.1.1 APAC Fluorine-18 Radiopharmaceuticals Sales by Region (2021-2026)
6.1.2 APAC Fluorine-18 Radiopharmaceuticals Revenue by Region (2021-2026)
6.2 APAC Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
6.3 APAC Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fluorine-18 Radiopharmaceuticals by Country
7.1.1 Europe Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
7.1.2 Europe Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
7.2 Europe Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
7.3 Europe Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fluorine-18 Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
8.2 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
8.3 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fluorine-18 Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Fluorine-18 Radiopharmaceuticals
10.4 Industry Chain Structure of Fluorine-18 Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fluorine-18 Radiopharmaceuticals Distributors
11.3 Fluorine-18 Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR FLUORINE-18 RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Fluorine-18 Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Fluorine-18 Radiopharmaceuticals Forecast by Region (2027-2032)
12.1.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fluorine-18 Radiopharmaceuticals Forecast by Type (2027-2032)
12.7 Global Fluorine-18 Radiopharmaceuticals Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 ANSTO
13.1.1 ANSTO Company Information
13.1.2 ANSTO Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 ANSTO Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 ANSTO Main Business Overview
13.1.5 ANSTO Latest Developments
13.2 Rosatom
13.2.1 Rosatom Company Information
13.2.2 Rosatom Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Rosatom Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Rosatom Main Business Overview
13.2.5 Rosatom Latest Developments
13.3 Eckert & Ziegler
13.3.1 Eckert & Ziegler Company Information
13.3.2 Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eckert & Ziegler Main Business Overview
13.3.5 Eckert & Ziegler Latest Developments
13.4 CNNC
13.4.1 CNNC Company Information
13.4.2 CNNC Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 CNNC Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CNNC Main Business Overview
13.4.5 CNNC Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Curium Pharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 GE HealthCare
13.6.1 GE HealthCare Company Information
13.6.2 GE HealthCare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 GE HealthCare Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GE HealthCare Main Business Overview
13.6.5 GE HealthCare Latest Developments
13.7 Jubilant Radiopharma
13.7.1 Jubilant Radiopharma Company Information
13.7.2 Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jubilant Radiopharma Main Business Overview
13.7.5 Jubilant Radiopharma Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Cardinal Health Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 IBA
13.9.1 IBA Company Information
13.9.2 IBA Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 IBA Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IBA Main Business Overview
13.9.5 IBA Latest Developments
13.10 Sumitomo Heavy Industries
13.10.1 Sumitomo Heavy Industries Company Information
13.10.2 Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sumitomo Heavy Industries Main Business Overview
13.10.5 Sumitomo Heavy Industries Latest Developments
13.11 Sinotau
13.11.1 Sinotau Company Information
13.11.2 Sinotau Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Sinotau Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sinotau Main Business Overview
13.11.5 Sinotau Latest Developments
13.12 Nueclear Healthcare
13.12.1 Nueclear Healthcare Company Information
13.12.2 Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.12.3 Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Nueclear Healthcare Main Business Overview
13.12.5 Nueclear Healthcare Latest Developments
13.13 DC Pharma
13.13.1 DC Pharma Company Information
13.13.2 DC Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.13.3 DC Pharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 DC Pharma Main Business Overview
13.13.5 DC Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fluorine-18 Radiopharmaceuticals by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fluorine-18 Radiopharmaceuticals by Country/Region, 2021, 2025 & 2032
2.2 Fluorine-18 Radiopharmaceuticals Segment by Type
2.2.1 Nucleophilic Labeling
2.2.2 Electrophilic Labeling
2.2.3 Fluorine-18 Radiopharmaceuticals Sales by Type
2.2.3.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Type (2021-2026)
2.3 Fluorine-18 Radiopharmaceuticals Segment by Functional
2.3.1 Metabolic Tracers
2.3.2 Receptor-Binding Tracers
2.3.3 Amino Acid Transporters
2.3.4 Others
2.3.5 Fluorine-18 Radiopharmaceuticals Sales by Functional
2.3.5.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional (2021-2026)
2.3.5.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Functional (2021-2026)
2.3.5.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Functional (2021-2026)
2.4 Fluorine-18 Radiopharmaceuticals Segment by Specific Activity
2.4.1 High Specific Activity
2.4.2 Low Specific Activity
2.4.3 Fluorine-18 Radiopharmaceuticals Sales by Specific Activity
2.4.3.1 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity (2021-2026)
2.4.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Specific Activity (2021-2026)
2.4.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Specific Activity (2021-2026)
2.5 Fluorine-18 Radiopharmaceuticals Segment by Application
2.5.1 Medical Imaging
2.5.2 Scientific Research
2.5.3 Fluorine-18 Radiopharmaceuticals Sales by Application
2.5.3.1 Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2021-2026)
2.5.3.2 Global Fluorine-18 Radiopharmaceuticals Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fluorine-18 Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Company (2021-2026)
3.1.2 Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company (2021-2026)
3.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Company (2021-2026)
3.2.1 Global Fluorine-18 Radiopharmaceuticals Revenue by Company (2021-2026)
3.2.2 Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company (2021-2026)
3.3 Global Fluorine-18 Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Fluorine-18 Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fluorine-18 Radiopharmaceuticals Product Location Distribution
3.4.2 Players Fluorine-18 Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLUORINE-18 RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Fluorine-18 Radiopharmaceuticals Market Size by Geographic Region (2021-2026)
4.1.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fluorine-18 Radiopharmaceuticals Market Size by Country/Region (2021-2026)
4.2.1 Global Fluorine-18 Radiopharmaceuticals Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fluorine-18 Radiopharmaceuticals Sales Growth
4.4 APAC Fluorine-18 Radiopharmaceuticals Sales Growth
4.5 Europe Fluorine-18 Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Fluorine-18 Radiopharmaceuticals Sales by Country
5.1.1 Americas Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
5.1.2 Americas Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
5.2 Americas Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
5.3 Americas Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fluorine-18 Radiopharmaceuticals Sales by Region
6.1.1 APAC Fluorine-18 Radiopharmaceuticals Sales by Region (2021-2026)
6.1.2 APAC Fluorine-18 Radiopharmaceuticals Revenue by Region (2021-2026)
6.2 APAC Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
6.3 APAC Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fluorine-18 Radiopharmaceuticals by Country
7.1.1 Europe Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
7.1.2 Europe Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
7.2 Europe Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
7.3 Europe Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fluorine-18 Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026)
8.2 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026)
8.3 Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fluorine-18 Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Fluorine-18 Radiopharmaceuticals
10.4 Industry Chain Structure of Fluorine-18 Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fluorine-18 Radiopharmaceuticals Distributors
11.3 Fluorine-18 Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR FLUORINE-18 RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Fluorine-18 Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Fluorine-18 Radiopharmaceuticals Forecast by Region (2027-2032)
12.1.2 Global Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fluorine-18 Radiopharmaceuticals Forecast by Type (2027-2032)
12.7 Global Fluorine-18 Radiopharmaceuticals Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 ANSTO
13.1.1 ANSTO Company Information
13.1.2 ANSTO Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 ANSTO Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 ANSTO Main Business Overview
13.1.5 ANSTO Latest Developments
13.2 Rosatom
13.2.1 Rosatom Company Information
13.2.2 Rosatom Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Rosatom Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Rosatom Main Business Overview
13.2.5 Rosatom Latest Developments
13.3 Eckert & Ziegler
13.3.1 Eckert & Ziegler Company Information
13.3.2 Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eckert & Ziegler Main Business Overview
13.3.5 Eckert & Ziegler Latest Developments
13.4 CNNC
13.4.1 CNNC Company Information
13.4.2 CNNC Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 CNNC Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CNNC Main Business Overview
13.4.5 CNNC Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Curium Pharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 GE HealthCare
13.6.1 GE HealthCare Company Information
13.6.2 GE HealthCare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 GE HealthCare Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GE HealthCare Main Business Overview
13.6.5 GE HealthCare Latest Developments
13.7 Jubilant Radiopharma
13.7.1 Jubilant Radiopharma Company Information
13.7.2 Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jubilant Radiopharma Main Business Overview
13.7.5 Jubilant Radiopharma Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Cardinal Health Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 IBA
13.9.1 IBA Company Information
13.9.2 IBA Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 IBA Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IBA Main Business Overview
13.9.5 IBA Latest Developments
13.10 Sumitomo Heavy Industries
13.10.1 Sumitomo Heavy Industries Company Information
13.10.2 Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sumitomo Heavy Industries Main Business Overview
13.10.5 Sumitomo Heavy Industries Latest Developments
13.11 Sinotau
13.11.1 Sinotau Company Information
13.11.2 Sinotau Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.11.3 Sinotau Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sinotau Main Business Overview
13.11.5 Sinotau Latest Developments
13.12 Nueclear Healthcare
13.12.1 Nueclear Healthcare Company Information
13.12.2 Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.12.3 Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Nueclear Healthcare Main Business Overview
13.12.5 Nueclear Healthcare Latest Developments
13.13 DC Pharma
13.13.1 DC Pharma Company Information
13.13.2 DC Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
13.13.3 DC Pharma Fluorine-18 Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 DC Pharma Main Business Overview
13.13.5 DC Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Fluorine-18 Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fluorine-18 Radiopharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nucleophilic Labeling
Table 4. Major Players of Electrophilic Labeling
Table 5. Global Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 6. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Table 7. Global Fluorine-18 Radiopharmaceuticals Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Type (2021-2026)
Table 9. Global Fluorine-18 Radiopharmaceuticals Sale Price by Type (2021-2026) & (US$/GBq)
Table 10. Major Players of Metabolic Tracers
Table 11. Major Players of Receptor-Binding Tracers
Table 12. Major Players of Amino Acid Transporters
Table 13. Major Players of Others
Table 14. Global Fluorine-18 Radiopharmaceuticals Sales by Functional (2021-2026) & (GBq)
Table 15. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional (2021-2026)
Table 16. Global Fluorine-18 Radiopharmaceuticals Revenue by Functional (2021-2026) & ($ million)
Table 17. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Functional (2021-2026)
Table 18. Global Fluorine-18 Radiopharmaceuticals Sale Price by Functional (2021-2026) & (US$/GBq)
Table 19. Major Players of High Specific Activity
Table 20. Major Players of Low Specific Activity
Table 21. Global Fluorine-18 Radiopharmaceuticals Sales by Specific Activity (2021-2026) & (GBq)
Table 22. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity (2021-2026)
Table 23. Global Fluorine-18 Radiopharmaceuticals Revenue by Specific Activity (2021-2026) & ($ million)
Table 24. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Specific Activity (2021-2026)
Table 25. Global Fluorine-18 Radiopharmaceuticals Sale Price by Specific Activity (2021-2026) & (US$/GBq)
Table 26. Global Fluorine-18 Radiopharmaceuticals Sale by Application (2021-2026) & (GBq)
Table 27. Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2021-2026)
Table 28. Global Fluorine-18 Radiopharmaceuticals Revenue by Application (2021-2026) & ($ million)
Table 29. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Application (2021-2026)
Table 30. Global Fluorine-18 Radiopharmaceuticals Sale Price by Application (2021-2026) & (US$/GBq)
Table 31. Global Fluorine-18 Radiopharmaceuticals Sales by Company (2021-2026) & (GBq)
Table 32. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company (2021-2026)
Table 33. Global Fluorine-18 Radiopharmaceuticals Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company (2021-2026)
Table 35. Global Fluorine-18 Radiopharmaceuticals Sale Price by Company (2021-2026) & (US$/GBq)
Table 36. Key Manufacturers Fluorine-18 Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 37. Players Fluorine-18 Radiopharmaceuticals Products Offered
Table 38. Fluorine-18 Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Fluorine-18 Radiopharmaceuticals Sales by Geographic Region (2021-2026) & (GBq)
Table 42. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Geographic Region (2021-2026)
Table 43. Global Fluorine-18 Radiopharmaceuticals Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Fluorine-18 Radiopharmaceuticals Sales by Country/Region (2021-2026) & (GBq)
Table 46. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2021-2026)
Table 47. Global Fluorine-18 Radiopharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 50. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Country (2021-2026)
Table 51. Americas Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 53. Americas Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 54. APAC Fluorine-18 Radiopharmaceuticals Sales by Region (2021-2026) & (GBq)
Table 55. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Region (2021-2026)
Table 56. APAC Fluorine-18 Radiopharmaceuticals Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 58. APAC Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 59. Europe Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 60. Europe Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 62. Europe Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 63. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 64. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 66. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 67. Key Market Drivers & Growth Opportunities of Fluorine-18 Radiopharmaceuticals
Table 68. Key Market Challenges & Risks of Fluorine-18 Radiopharmaceuticals
Table 69. Key Industry Trends of Fluorine-18 Radiopharmaceuticals
Table 70. Fluorine-18 Radiopharmaceuticals Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Fluorine-18 Radiopharmaceuticals Distributors List
Table 73. Fluorine-18 Radiopharmaceuticals Customer List
Table 74. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Region (2027-2032) & (GBq)
Table 75. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 77. Americas Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Fluorine-18 Radiopharmaceuticals Sales Forecast by Region (2027-2032) & (GBq)
Table 79. APAC Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 81. Europe Fluorine-18 Radiopharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 83. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Type (2027-2032) & (GBq)
Table 85. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Application (2027-2032) & (GBq)
Table 87. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. ANSTO Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. ANSTO Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 90. ANSTO Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 91. ANSTO Main Business
Table 92. ANSTO Latest Developments
Table 93. Rosatom Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Rosatom Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Rosatom Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 96. Rosatom Main Business
Table 97. Rosatom Latest Developments
Table 98. Eckert & Ziegler Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 101. Eckert & Ziegler Main Business
Table 102. Eckert & Ziegler Latest Developments
Table 103. CNNC Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. CNNC Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 105. CNNC Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 106. CNNC Main Business
Table 107. CNNC Latest Developments
Table 108. Curium Pharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Curium Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Curium Pharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 111. Curium Pharma Main Business
Table 112. Curium Pharma Latest Developments
Table 113. GE HealthCare Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. GE HealthCare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 115. GE HealthCare Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 116. GE HealthCare Main Business
Table 117. GE HealthCare Latest Developments
Table 118. Jubilant Radiopharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 120. Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 121. Jubilant Radiopharma Main Business
Table 122. Jubilant Radiopharma Latest Developments
Table 123. Cardinal Health Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Cardinal Health Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Cardinal Health Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 126. Cardinal Health Main Business
Table 127. Cardinal Health Latest Developments
Table 128. IBA Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. IBA Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 130. IBA Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 131. IBA Main Business
Table 132. IBA Latest Developments
Table 133. Sumitomo Heavy Industries Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 135. Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 136. Sumitomo Heavy Industries Main Business
Table 137. Sumitomo Heavy Industries Latest Developments
Table 138. Sinotau Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Sinotau Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 140. Sinotau Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 141. Sinotau Main Business
Table 142. Sinotau Latest Developments
Table 143. Nueclear Healthcare Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 145. Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 146. Nueclear Healthcare Main Business
Table 147. Nueclear Healthcare Latest Developments
Table 148. DC Pharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 149. DC Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 150. DC Pharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 151. DC Pharma Main Business
Table 152. DC Pharma Latest Developments
Table 1. Fluorine-18 Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fluorine-18 Radiopharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nucleophilic Labeling
Table 4. Major Players of Electrophilic Labeling
Table 5. Global Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 6. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Table 7. Global Fluorine-18 Radiopharmaceuticals Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Type (2021-2026)
Table 9. Global Fluorine-18 Radiopharmaceuticals Sale Price by Type (2021-2026) & (US$/GBq)
Table 10. Major Players of Metabolic Tracers
Table 11. Major Players of Receptor-Binding Tracers
Table 12. Major Players of Amino Acid Transporters
Table 13. Major Players of Others
Table 14. Global Fluorine-18 Radiopharmaceuticals Sales by Functional (2021-2026) & (GBq)
Table 15. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional (2021-2026)
Table 16. Global Fluorine-18 Radiopharmaceuticals Revenue by Functional (2021-2026) & ($ million)
Table 17. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Functional (2021-2026)
Table 18. Global Fluorine-18 Radiopharmaceuticals Sale Price by Functional (2021-2026) & (US$/GBq)
Table 19. Major Players of High Specific Activity
Table 20. Major Players of Low Specific Activity
Table 21. Global Fluorine-18 Radiopharmaceuticals Sales by Specific Activity (2021-2026) & (GBq)
Table 22. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity (2021-2026)
Table 23. Global Fluorine-18 Radiopharmaceuticals Revenue by Specific Activity (2021-2026) & ($ million)
Table 24. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Specific Activity (2021-2026)
Table 25. Global Fluorine-18 Radiopharmaceuticals Sale Price by Specific Activity (2021-2026) & (US$/GBq)
Table 26. Global Fluorine-18 Radiopharmaceuticals Sale by Application (2021-2026) & (GBq)
Table 27. Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2021-2026)
Table 28. Global Fluorine-18 Radiopharmaceuticals Revenue by Application (2021-2026) & ($ million)
Table 29. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Application (2021-2026)
Table 30. Global Fluorine-18 Radiopharmaceuticals Sale Price by Application (2021-2026) & (US$/GBq)
Table 31. Global Fluorine-18 Radiopharmaceuticals Sales by Company (2021-2026) & (GBq)
Table 32. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company (2021-2026)
Table 33. Global Fluorine-18 Radiopharmaceuticals Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company (2021-2026)
Table 35. Global Fluorine-18 Radiopharmaceuticals Sale Price by Company (2021-2026) & (US$/GBq)
Table 36. Key Manufacturers Fluorine-18 Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 37. Players Fluorine-18 Radiopharmaceuticals Products Offered
Table 38. Fluorine-18 Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Fluorine-18 Radiopharmaceuticals Sales by Geographic Region (2021-2026) & (GBq)
Table 42. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Geographic Region (2021-2026)
Table 43. Global Fluorine-18 Radiopharmaceuticals Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Fluorine-18 Radiopharmaceuticals Sales by Country/Region (2021-2026) & (GBq)
Table 46. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2021-2026)
Table 47. Global Fluorine-18 Radiopharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 50. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Country (2021-2026)
Table 51. Americas Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 53. Americas Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 54. APAC Fluorine-18 Radiopharmaceuticals Sales by Region (2021-2026) & (GBq)
Table 55. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Region (2021-2026)
Table 56. APAC Fluorine-18 Radiopharmaceuticals Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 58. APAC Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 59. Europe Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 60. Europe Fluorine-18 Radiopharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 62. Europe Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 63. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Country (2021-2026) & (GBq)
Table 64. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Type (2021-2026) & (GBq)
Table 66. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales by Application (2021-2026) & (GBq)
Table 67. Key Market Drivers & Growth Opportunities of Fluorine-18 Radiopharmaceuticals
Table 68. Key Market Challenges & Risks of Fluorine-18 Radiopharmaceuticals
Table 69. Key Industry Trends of Fluorine-18 Radiopharmaceuticals
Table 70. Fluorine-18 Radiopharmaceuticals Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Fluorine-18 Radiopharmaceuticals Distributors List
Table 73. Fluorine-18 Radiopharmaceuticals Customer List
Table 74. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Region (2027-2032) & (GBq)
Table 75. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 77. Americas Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Fluorine-18 Radiopharmaceuticals Sales Forecast by Region (2027-2032) & (GBq)
Table 79. APAC Fluorine-18 Radiopharmaceuticals Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 81. Europe Fluorine-18 Radiopharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (GBq)
Table 83. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Type (2027-2032) & (GBq)
Table 85. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Fluorine-18 Radiopharmaceuticals Sales Forecast by Application (2027-2032) & (GBq)
Table 87. Global Fluorine-18 Radiopharmaceuticals Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. ANSTO Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. ANSTO Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 90. ANSTO Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 91. ANSTO Main Business
Table 92. ANSTO Latest Developments
Table 93. Rosatom Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Rosatom Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Rosatom Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 96. Rosatom Main Business
Table 97. Rosatom Latest Developments
Table 98. Eckert & Ziegler Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Eckert & Ziegler Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 101. Eckert & Ziegler Main Business
Table 102. Eckert & Ziegler Latest Developments
Table 103. CNNC Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. CNNC Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 105. CNNC Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 106. CNNC Main Business
Table 107. CNNC Latest Developments
Table 108. Curium Pharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Curium Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Curium Pharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 111. Curium Pharma Main Business
Table 112. Curium Pharma Latest Developments
Table 113. GE HealthCare Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. GE HealthCare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 115. GE HealthCare Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 116. GE HealthCare Main Business
Table 117. GE HealthCare Latest Developments
Table 118. Jubilant Radiopharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 120. Jubilant Radiopharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 121. Jubilant Radiopharma Main Business
Table 122. Jubilant Radiopharma Latest Developments
Table 123. Cardinal Health Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Cardinal Health Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 125. Cardinal Health Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 126. Cardinal Health Main Business
Table 127. Cardinal Health Latest Developments
Table 128. IBA Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. IBA Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 130. IBA Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 131. IBA Main Business
Table 132. IBA Latest Developments
Table 133. Sumitomo Heavy Industries Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 135. Sumitomo Heavy Industries Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 136. Sumitomo Heavy Industries Main Business
Table 137. Sumitomo Heavy Industries Latest Developments
Table 138. Sinotau Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Sinotau Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 140. Sinotau Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 141. Sinotau Main Business
Table 142. Sinotau Latest Developments
Table 143. Nueclear Healthcare Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 145. Nueclear Healthcare Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 146. Nueclear Healthcare Main Business
Table 147. Nueclear Healthcare Latest Developments
Table 148. DC Pharma Basic Information, Fluorine-18 Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 149. DC Pharma Fluorine-18 Radiopharmaceuticals Product Portfolios and Specifications
Table 150. DC Pharma Fluorine-18 Radiopharmaceuticals Sales (GBq), Revenue ($ Million), Price (US$/GBq) and Gross Margin (2021-2026)
Table 151. DC Pharma Main Business
Table 152. DC Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Fluorine-18 Radiopharmaceuticals
Figure 2. Fluorine-18 Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fluorine-18 Radiopharmaceuticals Sales Growth Rate 2021-2032 (GBq)
Figure 7. Global Fluorine-18 Radiopharmaceuticals Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fluorine-18 Radiopharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2025)
Figure 10. Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Nucleophilic Labeling
Figure 12. Product Picture of Electrophilic Labeling
Figure 13. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type in 2026
Figure 14. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Metabolic Tracers
Figure 16. Product Picture of Receptor-Binding Tracers
Figure 17. Product Picture of Amino Acid Transporters
Figure 18. Product Picture of Others
Figure 19. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional in 2026
Figure 20. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Functional (2021-2026)
Figure 21. Product Picture of High Specific Activity
Figure 22. Product Picture of Low Specific Activity
Figure 23. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity in 2026
Figure 24. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Specific Activity (2021-2026)
Figure 25. Fluorine-18 Radiopharmaceuticals Consumed in Medical Imaging
Figure 26. Global Fluorine-18 Radiopharmaceuticals Market: Medical Imaging (2021-2026) & (GBq)
Figure 27. Fluorine-18 Radiopharmaceuticals Consumed in Scientific Research
Figure 28. Global Fluorine-18 Radiopharmaceuticals Market: Scientific Research (2021-2026) & (GBq)
Figure 29. Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2025)
Figure 30. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 31. Fluorine-18 Radiopharmaceuticals Sales by Company in 2025 (GBq)
Figure 32. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 33. Fluorine-18 Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 34. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 35. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 38. Americas Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 39. APAC Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 40. APAC Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 41. Europe Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 42. Europe Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 44. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 45. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 46. Americas Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 47. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 48. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 49. United States Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 54. APAC Fluorine-18 Radiopharmaceuticals Revenue Market Share by Region (2021-2026)
Figure 55. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 56. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 57. China Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 61. India Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 65. Europe Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 66. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 67. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 68. Germany Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 69. France Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 76. Egypt Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Fluorine-18 Radiopharmaceuticals in 2026
Figure 82. Manufacturing Process Analysis of Fluorine-18 Radiopharmaceuticals
Figure 83. Industry Chain Structure of Fluorine-18 Radiopharmaceuticals
Figure 84. Channels of Distribution
Figure 85. Global Fluorine-18 Radiopharmaceuticals Sales Market Forecast by Region (2027-2032)
Figure 86. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Fluorine-18 Radiopharmaceuticals
Figure 2. Fluorine-18 Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fluorine-18 Radiopharmaceuticals Sales Growth Rate 2021-2032 (GBq)
Figure 7. Global Fluorine-18 Radiopharmaceuticals Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fluorine-18 Radiopharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2025)
Figure 10. Fluorine-18 Radiopharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Nucleophilic Labeling
Figure 12. Product Picture of Electrophilic Labeling
Figure 13. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Type in 2026
Figure 14. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Metabolic Tracers
Figure 16. Product Picture of Receptor-Binding Tracers
Figure 17. Product Picture of Amino Acid Transporters
Figure 18. Product Picture of Others
Figure 19. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Functional in 2026
Figure 20. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Functional (2021-2026)
Figure 21. Product Picture of High Specific Activity
Figure 22. Product Picture of Low Specific Activity
Figure 23. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Specific Activity in 2026
Figure 24. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Specific Activity (2021-2026)
Figure 25. Fluorine-18 Radiopharmaceuticals Consumed in Medical Imaging
Figure 26. Global Fluorine-18 Radiopharmaceuticals Market: Medical Imaging (2021-2026) & (GBq)
Figure 27. Fluorine-18 Radiopharmaceuticals Consumed in Scientific Research
Figure 28. Global Fluorine-18 Radiopharmaceuticals Market: Scientific Research (2021-2026) & (GBq)
Figure 29. Global Fluorine-18 Radiopharmaceuticals Sale Market Share by Application (2025)
Figure 30. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 31. Fluorine-18 Radiopharmaceuticals Sales by Company in 2025 (GBq)
Figure 32. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 33. Fluorine-18 Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 34. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 35. Global Fluorine-18 Radiopharmaceuticals Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 38. Americas Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 39. APAC Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 40. APAC Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 41. Europe Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 42. Europe Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales 2021-2026 (GBq)
Figure 44. Middle East & Africa Fluorine-18 Radiopharmaceuticals Revenue 2021-2026 ($ millions)
Figure 45. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 46. Americas Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 47. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 48. Americas Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 49. United States Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 54. APAC Fluorine-18 Radiopharmaceuticals Revenue Market Share by Region (2021-2026)
Figure 55. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 56. APAC Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 57. China Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 61. India Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 65. Europe Fluorine-18 Radiopharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 66. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 67. Europe Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 68. Germany Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 69. France Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Fluorine-18 Radiopharmaceuticals Sales Market Share by Application (2021-2026)
Figure 76. Egypt Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Fluorine-18 Radiopharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Fluorine-18 Radiopharmaceuticals in 2026
Figure 82. Manufacturing Process Analysis of Fluorine-18 Radiopharmaceuticals
Figure 83. Industry Chain Structure of Fluorine-18 Radiopharmaceuticals
Figure 84. Channels of Distribution
Figure 85. Global Fluorine-18 Radiopharmaceuticals Sales Market Forecast by Region (2027-2032)
Figure 86. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Fluorine-18 Radiopharmaceuticals Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Fluorine-18 Radiopharmaceuticals Revenue Market Share Forecast by Application (2027-2032)
